Fluphenazine enanthate

Fluphenazine enanthate Structure
Fluphenazine enanthate structure
Common Name Fluphenazine enanthate
CAS Number 2746-81-8 Molecular Weight 549.69100
Density 1.181g/cm3 Boiling Point 629.4ºC at 760mmHg
Molecular Formula C29H38F3N3O2S Melting Point N/A
MSDS N/A Flash Point 334.4ºC

Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review.

Int. Clin. Psychopharmacol. 28(5) , 261-6, (2013)

Long-term follow-up data of patients with schizophrenia on depot antipsychotics have been few and the longest follow-up period has been up to 7 years. We carried out a systematic chart review to examine 10-year outcomes for outpatients with schizophrenia who ...

Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.

Schizophr. Res. 119(1-3) , 153-9, (2010)

This study aimed to characterize the inpatient utilization of depot antipsychotics.The characteristics of adults with schizophrenia or schizoaffective disorder, hospitalized for at least 28 days, and who were prescribed depot antipsychotics were examined from...

Multiple congenital abnormalities in a newborn boy associated with maternal use of fluphenazine enanthate and other drugs during pregnancy.

Acta Paediatr. Scand. 71(2) , 335-8, (1982)

A boy was born with a short sloping forehead, wide metopic suture, persistent metopic fontanelle, telecanthus, ocular hypertelorism, nystagmoid eye movements, bilateral cleft lip and palate, imperforate anus, rectourethral fistula, bifid scrotum and an unusua...

[Effect of a single dose of some long-acting neuroleptics on the estrus cycle and the mammary gland of the rat].

C. R. Seances. Soc. Biol. Fil. 173(4) , 797-806, (1979)

The effects of two neuroleptics (pipotiazine and fluphenazine) and five long-acting neuroleptics (pipotiazine undecylenate and palmitate, fluphenazine enanthate and decanoate, fluopentixol decanoate) are tested in the rat, during an observation period of 20 t...

Animal model for investigation of fluphenazine kinetics after administration of long-acting esters.

Biopharm. Drug Dispos. 1(2) , 65-72, (1979)

A model was developed for studying fluphenazine availability and disposition. Rats were given doses of radioactively labelled esters of fluphenazine by intramuscular injection. Radioactivity excreted in urine, faeces, and expired air was assessed for fluphena...

Neuroleptic malignant syndrome.

South. Med. J. 79(3) , 331-6, (1986)

The neuroleptic malignant syndrome (NMS) is a rare but potentially lethal disorder associated with the administration of neuroleptic agents. This syndrome may be underdiagnosed because it is poorly understood and often unrecognized. It affects all age groups ...

More than mere shots.

Am. J. Nurs. 88(5) , 664-7, (1988)

Catalepsy produced by long-acting neuroleptics, fluphenazine enanthate and fluphenazine decanoate, in mice.

Pharmacology 24(3) , 147-55, (1982)

The cataleptic state induced by the depot-type preparations of fluphenazine (FZ) was investigated in mice. Intramuscular injections of FZ-enanthate or FZ-decanoate produced a marked and long-lasting catalepsy, which was antagonized by trihexyphenidyl, biperid...

The Pisa syndrome during maintenance antipsychotic therapy.

Am. J. Psychiatry 143(11) , 1492, (1986)

Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.

Am. J. Psychiatry 139(3) , 312-8, (1982)